2 weeks Ago By ABMN Staff
Northwest Biotherapeutics, Inc. ( OTCMKTS:NWBO – Get Free Report ) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.
42 and traded as low as $0.32. Northwest Biotherapeutics shares last traded at $0.
33, with a volume of 931,730 shares trading hands. Northwest Biotherapeutics Stock Up 2.2 % The firm has a market capitalization of $400.
02 million, a price-to-earnings ratio of -4.64 and a beta of -0.58.
The stock’s 50 day moving average price is $0.33 and its two-hundred day moving average price is $0.42.
Northwest Biotherapeutics ( OTCMKTS:NWBO – Get Free Report ) last released its quarterly earnings data on Friday, August 9th. The biotechnology company reported ($0.02) EPS for the quarter.
The company had revenue of $0.51 million during the quarter. About Northwest Biotherapeutics Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally.
The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. See Also Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter .
.
